Eris Lifesciences Ltd.
ERISHealthcareR1 raw held document library
Coverage
| Dataset | On disk | Usable | State |
|---|---|---|---|
| Results XBRL (NSE + BSE) | 102 | 34 | 34 quarter-ends |
| Annual reports | 10 | 10 | identity graded |
| Earnings calls | 21 | 0 | transcripts and analyst meets only |
| Shareholding | 34 | 34 | |
| Related party | 7 | 7 | |
| Investor decks | 0 | 0 | cohort of 48 companies only |
Financial statements in parse — expected 19 Sep 2026. Nothing from the superseded legacy store is shown.
Earnings calls
21 transcript(s)/analyst meet(s) served; 21 document(s) on file are not transcripts (cover letters, duplicates, unresolved) and are excluded. Speaker attribution is shown only where the segmenter attributes ≥ 95% of sentences to management or analysts (0 of 21 documents here); elsewhere sentences render unattributed.
| Kind | Date | Period | Served | Attribution rate |
|---|---|---|---|---|
| COVER_LETTER | 20210722 | 2021-06-30 | no | |
| COVER_LETTER | 20211101 | 2021-09-30 | no | |
| COVER_LETTER | 20220203 | 2021-12-31 | no | |
| COVER_LETTER | 20220510 | 2022-03-31 | no | |
| COVER_LETTER | 20220811 | 2022-06-30 | no | |
| COVER_LETTER | 20221031 | 2022-09-30 | no | |
| COVER_LETTER | 20230123 | 2022-12-31 | no | |
| COVER_LETTER | 20230522 | 2023-03-31 | no | |
| COVER_LETTER | 20230811 | 2023-06-30 | no | |
| COVER_LETTER | 20231111 | 2023-09-30 | no | |
| COVER_LETTER | 20240220 | 2023-12-31 | no | |
| COVER_LETTER | 20240528 | 2024-03-31 | no | |
| COVER_LETTER | 20240807 | 2024-06-30 | no | |
| COVER_LETTER | 20241104 | 2024-09-30 | no | |
| COVER_LETTER | 20250211 | 2024-12-31 | no | |
| COVER_LETTER | 20250526 | 2025-03-31 | no | |
| COVER_LETTER | 20250811 | 2025-06-30 | no | |
| COVER_LETTER | 20251114 | 2025-09-30 | no | |
| COVER_LETTER | 20260220 | 2025-12-31 | no | |
| COVER_LETTER | 20260526 | 2026-03-31 | no | |
| COVER_LETTER | 20260804 | 2026-06-30 | no |